Evercore ISI analyst Vijay Kumar resumed coverage of OraSure with an In Line rating and $5 price target. OraSure’s base business ex-COVID "has been spotty" and for now, it seems OraSure "is in a bit of no-mans land until we see execution," Kumar tells investors.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on OSUR:
- OraSure reaffirms dedication to end HIV epidemic
- OraSure Technologies Continues its Dedication to Ending the HIV Epidemic
- OraSure Technologies to Present at Stephens Annual Investment Conference
- OraSure reports Q3 EPS 13c, consensus (4c)
- OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year